Wuhan General Group (China), Inc. (WUHN)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 9, 2025
WUHN Revenue
In the year 2012, Wuhan General Group (China) had annual revenue of $80.38M, down -36.96%.
Revenue
80.38M
Revenue Growth
-36.96%
P/S Ratio
0.00
Revenue / Employee
114.82K
Employees
700
Market Cap
5.52K
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| Silence Therapeutics | 27.70M |
Wuhan General Group (China) News
- 3 years ago - Wuhan General Group China Announces Corporate Update - Accesswire
- 3 years ago - Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs - Accesswire
- 3 years ago - Medspresso and Liviana Carried by 100 Independent South African Retailers - Accesswire
- 3 years ago - M2Bio Sciences Attending Master Investor Show in London, UK - Accesswire
- 3 years ago - M2Bio Labs Offers Ketamine IV & Personalized Supercharged Vitamin IV Drip - Accesswire
- 3 years ago - Medspresso Joins the Speciality Coffee Association of South Africa - Accesswire
- 3 years ago - Medspresso Launches CBD and Functional Mushroom Single Serve Sachets - Accesswire
- 3 years ago - Wuhan General Group Launches Mental Illness Drug Discovery Company Neurai Life Sciences - Accesswire